NCT06723691View on ClinicalTrials.gov

Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 18, 2024

Primary Completion Date

June 9, 2025

Study Completion Date

June 9, 2025

Conditions

Type 2 Diabetes

Interventions

DRUG

Acetaminophen

DRUG

Metformin

DRUG

Warfarin

DRUG

Atorvastatin

DRUG

Digoxin

DRUG

HRS9531

Trial Locations (1)

230000

The Second Affiliated Hospital of Anhui Medical University, Hefei

All Listed Sponsors

lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY

NCT06723691 - Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects | Biotech Hunter | Biotech Hunter